Los Angeles Capital Management’s AngioDynamics ANGO Stock Holding History

Los Angeles Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.63K	Hold	231	–	–	﹤0.01%	2256
2025 Q4	$2.8K	Buy	+231	New	+$2.85K	﹤0.01%	2386
2025 Q3	–	Sell	-14,011	Closed	-$139K	–	1361
2025 Q2	$139K	Buy	+14,011	New	+$137K	﹤0.01%	1232
2020 Q3	–	Sell	-54,980	Closed	-$559K	–	1429
2020 Q2	$559K	Buy	54,980 +24,227	+79%	+$250K	﹤0.01%	1068
2020 Q1	$321K	Buy	+30,753	New	+$386K	﹤0.01%	1029

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Los Angeles Capital Management's ANGO Position: Q1 2026 in Review

Los Angeles Capital Management held its AngioDynamics (ANGO) position steady in Q1 2026 at 231 shares worth $2.63K. The position accounts for ﹤0.01% of the portfolio, ranked #2256.

Los Angeles Capital Management first reported a position in ANGO in Q1 2020 and has held it in 5 quarters since. The position peaked at $559K in Q2 2020. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Los Angeles Capital Management held 231 shares of AngioDynamics worth $2.63K as of Q1 2026.
Los Angeles Capital Management left its AngioDynamics share count unchanged in Q1 2026.
AngioDynamics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #2256 holding.
Los Angeles Capital Management first reported a position in AngioDynamics in Q1 2020 and has held it in 5 quarters since.
Los Angeles Capital Management's AngioDynamics position peaked at $559K in Q2 2020.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.